share_log

BioVie | 4: Statement of changes in beneficial ownership of securities-Officer Palumbo Joseph M

SEC ·  Jul 13, 2024 06:02

Summary by Moomoo AI

BioVie Inc.'s Chief Medical Officer, Joseph M Palumbo, completed a series of transactions involving the company's common stock. On February 16, 2023, Palumbo sold 2,476 shares at a price of $5.51 per share. Subsequent transactions included the disposal of additional shares on February 15, 2024, and June 24, 2024, at prices of $1.18 and $0.474 respectively, with the latter date also marking the acquisition of 116,000 shares at no cost, likely due to a grant or award. After these transactions, Palumbo's direct holdings in BioVie common stock amounted to 119,196 shares. The total market value of the disposed shares was calculated at $30,310.44.
BioVie Inc.'s Chief Medical Officer, Joseph M Palumbo, completed a series of transactions involving the company's common stock. On February 16, 2023, Palumbo sold 2,476 shares at a price of $5.51 per share. Subsequent transactions included the disposal of additional shares on February 15, 2024, and June 24, 2024, at prices of $1.18 and $0.474 respectively, with the latter date also marking the acquisition of 116,000 shares at no cost, likely due to a grant or award. After these transactions, Palumbo's direct holdings in BioVie common stock amounted to 119,196 shares. The total market value of the disposed shares was calculated at $30,310.44.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more